High‐dose insulin should be used before vasopressors/inotropes in calcium‐channel blocker toxicity
British Journal of Clinical Pharmacology · 2023
DOI: 10.1111/bcp.15641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Bruno Mégarbane. Beteiligte Einrichtung: Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris, France. Hauptthemen laut MEDLINE: Insulin, Calcium Channel Blockers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
High‐dose insulin (HDI) therapy with adapted glucose supplementation to maintain euglycaemia has been suggested to treat calcium‐channel blocker (CCB) poisonings. Its underlying mechanisms of action are now well documented. We present a narrative review of the published experimental studies, case reports and experts' opinions to support the effectiveness and safety of HDI in the treatment of CCB poisoning. Our review strongly encourages the use of HDI as first‐line therapy in CCB‐poisoned patients in the presence of cardiovascular compromise, especially if cardiac function impairment has been diagnosed, before, but without delaying, the administration of vasopressors/inotropic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris, France.
- Inserm UMRS 1144, University of Paris, France.
ORCID-Profile: Bruno Mégarbane
Zitieren
APA
Mégarbane, B. (2023). High‐dose insulin should be used before vasopressors/inotropes in calcium‐channel blocker toxicity. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15641
Vancouver
Mégarbane B. High‐dose insulin should be used before vasopressors/inotropes in calcium‐channel blocker toxicity. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15641
BibTeX
@article{Mgarbane2023,
author = {Mégarbane, Bruno},
title = {High‐dose insulin should be used before vasopressors/inotropes in calcium‐channel blocker toxicity},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
doi = {10.1111/bcp.15641}
}
EUVIMED